SBRA Stock Forecast & Price Target

Sabra Health Care REIT is supported by stronger rent collections, accretive re-tenanting, and improved portfolio quality, highlighted by the 26 Avamere properties expected to generate about $53 million of annualized cash rent, roughly 30% above the prior $41 million, plus more than $9 million of incremental annual cash NOI from other lease actions. Its outlook also benefits from senior housing momentum, with $277 million of SHOP and SNF investments at a 7.9% initial cash yield, 14.4% same-store SHOP NOI growth in 1Q26, and management’s expectation that SHOP will reach 40% of gross assets by FYE26. Balance-sheet progress and guidance increases reinforce the thesis, as the RCA resolution reduced net debt-to-EBITDA to 4.8x, behavioral health exposure fell to 9% of annualized cash NOI, and normalized AFFO per share guidance rose to $1.59-$1.61 for 2026.

Sabra Health Care REIT is facing a negative fundamental setup because tenant operating weakness, heavy dependence on Medicaid, Medicare and other third-party reimbursements, and strict regulatory exposure could impair operators’ ability to pay rent and debt obligations. Its balance sheet and growth profile also appear constrained by reliance on external capital, meaningful debt risk, and intense REIT competition, while higher 2026 G&A expense guidance to $61 million adds further pressure to cash flow and FFO. Although management said normalized 2026 FFO remains $1.55 per share, a $100 million loss on debt extinguishment lowered the 2026 FFO estimate to $1.16 per share, underscoring earnings sensitivity and weaker near-term fundamentals.